Research Nester published a report titled “Catheter-Directed Thrombolysis Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global catheter-directed thrombolysis market in terms of market segmentation by delivery mode, indication, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global catheter-directed thrombolysis market anticipated to grow with a CAGR of ~10% over the forecast period, i.e., 2022 - 2031. The market is segmented by end-user into ambulatory surgical centers, hospitals, radiology clinics, and others. Amongst these, hospitals segment is estimated to grow at the highest rate during the forecast period backed by the escalating investments by the government in healthcare sector, and expanding number of patients of deep vein thrombosis, and pulmonary embolism.

Request Report Sample@ https://www.researchnester.com/sample-request-4220

The global catheter-directed thrombolysis market is projected to significantly grow owing to the growing occurrence of obesity, followed by the increasing number of several chronic diseases which is a leading cause of disability and death, and rising number of strokes are some of the major factors anticipated to drive the growth of the market in the forecast period.

Geographically, the global catheter-directed thrombolysis market is segmented into five major regions comprising of North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the North America region is estimated to witness significant growth over the forecast period owing to the rising disposable income, accessibility of advanced healthcare services, and proliferation in healthcare expenditure in the region.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Growing Prevalence of Chronic Diseases and Pulmonary Embolism to Drive the Market Growth

For instance, the prevalence of chronic diseases was increased by 59% in 2020. Additionally, a total of approximately 900,010 people per year suffer from deep vein thrombosis (DVT) or pulmonary embolism (PE).

Chronic diseases persist for long time and require a long treatment. With age, chronic diseases tend to become more prevalent. Chronic diseases consist of several other diseases such as heart disease, diabetes, stroke, cancer, and arthritis. These diseases are the leading causes of disability and death across the globe. On the other hand, pulmonary embolism is caused by blood clots that originate in deep leg veins and occasionally, veins in other parts of the body and proceed to the lungs. Pulmonary embolism causes a reduction in blood flow, which damages lung tissue. Low blood oxygen levels not only effect the heart but also harm the other body organs. Thus, such conditions require prompt and effective medical treatment and observation. Therefore, the increasing number of pulmonary embolism cases, and chronic diseases are fueling up the catheter-directed thrombolysis market.

However, associated risk with the catheter-directed thrombolysis, lack of advanced healthcare infrastructure in emerging nations, and shortage of expertise about the process are expected to operate as key restraint to the growth of global catheter-directed thrombolysis market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global catheter-directed thrombolysis market which includes company profiling of BrosMed Medical Co., Medtronic, Boston Scientific Corporation (BSC), Thrombolex, Inc., Inari Medical, Inc. Ivascular, S.L.U, Teleflex Incorporated, Penumbra, Inc., AngioDynamics, Inc. and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global catheter-directed thrombolysis market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Request Report Sample@ https://www.researchnester.com/sample-request-4220

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919